Oral controlled release formulations of rifampicin. Part II: Effect of formulation variables and process parameters on in vitro release

Drug Delivery

Volumn 15, Issue 3, 2008, Pages 159-168

  Hiremath, P S ^a   Saha, R N ^b  

^a WESTERN UNIVERSITY OF HEALTH SCIENCES   (United States)

^b BIRLA INSTITUTE OF TECHNOLOGY AND SCIENCE   (India)

Author keywords

Compression Force; Controlled Release; HPMC; Rifampicin; Viscosity

Indexed keywords

HYDROXYPROPYLMETHYLCELLULOSE; RIFAMPICIN;

ARTICLE; CONTROLLED RELEASE FORMULATION; DRUG EFFECT; DRUG RELEASE; IN VITRO STUDY; PARAMETER; PARTICLE SIZE; PRIORITY JOURNAL; VISCOSITY;

ADMINISTRATION, ORAL; ALGORITHMS; DELAYED-ACTION PREPARATIONS; DRUG COMPOUNDING; DRUG STABILITY; DRUG STORAGE; EXCIPIENTS; HARDNESS; KINETICS; METHYLCELLULOSE; PARTICLE SIZE; QUALITY CONTROL; RIFAMPIN; SOLUBILITY; TABLETS; TECHNOLOGY, PHARMACEUTICAL; TIME FACTORS; VISCOSITY;

EID: 41549091455     PISSN: 10717544     EISSN: 15210464     Source Type: Journal    
DOI: 10.1080/10717540801952498     Document Type: Article

References (24)

1. Capan, Y., Ciftci, K., and Hincal, A. A. 1991. Influence of filler excipients on the release rate of sustained release lithium carbonate tablets. Eur. J. Pharm. Biopharm. 37:14-18.
2. Colombo, P. 1993. Swelling-controlled release in hydrogel matrices for oral route. Adv. Drug Del. Rev. 11:37-57.
3. Eyjolfsson, R. 1999. Hydroxypropyl methylcellulose mixtures: effects and kinetics of release of an insoluble drug. Drug Dev. Ind. Pharm. 25:667-669.
4. Ford, J. L., Rubinstein, M. H., and Hogan, J. E. 1985. Formulation of sustained release promethazine hydrochloride tablets using hydroxypropyl methylcellulose matrices. Int. J. Pharm. 24:327-338.
5. Hiremath, S.P., and Saha, R.N. 2004. Design and study of rifampicin oral controlled release formulations. Drug Del. 11(5):311-317.
6. Huber, H. E., and Christenson, G. L. 1968. Utilization of hydrophilic gums for the control of drug substance from tablet formulations. II. Influence of tablet hardness and density on dissolution behavior. J. Pharm. Sci. 57:164-166.
7. Indian Pharmacopoeia, vol II. 1996. Government of India Ministry of Health and Family Welfare. New Delhi: The Controller Publications, 665-666.
8. Kim, H., and Fassihi, R. 1997. Application of binary polymer system in drug release rate modulation. 2. Influence of formulation variables and hydrodynamic conditions on release kinetics. J. Pharm. Sci. 86(3):32.
9. Lapidus, H., and Lordi, N. G. 1966. Some factors affecting the release rate of water-soluble drug from compressed hydrophilic matrix. J. Pharm. Sci. 55:840-843.
10. Lee, B.-J., Ryu, S. -G., and Cui, J. -H. 1999. Formulation and release characteristics of hydroxypropyl methylcellulose matrix tablet containing melatonin. Drug Dev. Ind. Pharm. 25(4):493-501.
11. Maggi, L., Machiste, E. O., Torre, M. L., and Conte, U. 1999. Formulation of biphasic release tablets containing slightly soluble drugs. Eur. J. Pharm. Biopharm. 48:37-42.
12. Nakano, M., Ohmani, N., Ogata, A., Sugimato, K., Tabino, Y., Iwaoku, R., and Kazuhiko, J. 1983. Sustained release of theophylline from hydroxypropyl cellulose tablets. J. Pharm. Sci. 72:378-380.
13. Nokhodchi, A., Ford, J. L., Rowe, P. H., and Rubinstein, M. H. 1996. The effects of compression rate and force on the compaction properties of different viscosity grades of hydroxypropyl methylcellulose. Int. J. Pharm. 129:21-31.
14. Rao, S. B., and Murthy, K. V. R. 2000. Preparation and in vitro evaluation of chitosan matrices cross-linked by formaldehyde vapors. Drug Dev. Ind. Pharm. 26(10):1085-1090.
15. Rao, S. B., and Murthy, K. V. R. 2001. Development of dissolution medium for rifampicin sustained release formulations. Ind. J. Pharm. Sci. 63(3):258-260.
16. Rao, S. B., and Murthy, K. V. R. 2002. Studies on rifampicin release fro ethylcellulose coated nonpareil beads. Int. J. Pharm. 231:97-106.
17. Rao, S. B., Seshasayana, A., Narayan, C. P. S., Sudha, K. S., Saradhi, S. V. P., Ravi Kumar, N., and Murthy K. V. R. 2001. Studies on release of rifampicin from sintered matrix tablets. Ind. J. Pharm. Sci. 63(5): 371-378.
18. Ritger, P. L., and Peppas, N. A. 1987. A simple equation for description of solute release. II. Fickian and anomalous release from swellable devices. J. Cont. Rel. 5:37-42.
19. Seng, C. H., Hasaesum, P., Peggy, K., and Robinson, J. R. 1985. Bioadhesive polymers as platforms for oral controlled release drug delivery II. Synthesis and evaluation of some swelling, water insoluble bioadhesive polymers. J. Pharm. Sci. 74:399-405.
20. Seshasayana, A., Rao, S. B., Raju, Y. P., Narayan, C. P. S., and Murthy, K. V. R. 2001. Studies on release of rifampicin from modified pulsnicap technique. Ind. J. Pharm. Sci. 63(4):337-339.
21. Shishoo, C. J., Shah, S. A., Rathod, I. S., Savale, S. S., Kotecha, J. S., and Shah, P. B. 1999. Stability of rifampicin in dissolution medium in presence of isoniazid. Int. J. Pharm. 190:109-123.
22. Siepmann, J., Kranz, H., Bodmeier, R., and Peppas, N. A. 1999. HPMC-Matrices for controlled drug delivery: A new model combining diffusion, swelling, and dissolution mechanisms and predicting release kinetics. Pharm. Res. 16(11):1748-1756.
23. Velasco, M., Ford, J. L., Rowe, P., and Rajabi-Siahboomi, A. R. 1999. Influence of drug:hydroxypropyl methylcellulose ratio, drug and polymer particle size and compression force on the release of diclofenac sodium from HPMC matrices. J. Contr. Rel. 57:75-85.
24. Verma, M. V. S., Kaushal, A. M., Garg, A., and Garg, S. 2004. Factors affecting mechanism and kinetics of drug release from matrix-based oral controlled drug delivery systems. Am. J. Drug. Del. 2(1):43-57.